300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
CleanTech
Enterprise Software
Local
Platforms
Travel
Oil and Gas
InsurTech
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Facebook
Renewable Energy
Software
Blockchain
Medical
Web3
Infrastructure
Theatre
Recruiting
Crowdfunding
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Venture Capital
Beauty
Fashion
Social
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Sweden
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Liberia
Isle of Man
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Czech Republic
Costa Rica
Marshall Islands
Kuwait
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Switzerland
Jamaica
Sri Lanka
Kazakhstan
Cayman Islands
Guatemala
Venezuela
Turkey
Uganda
Myanmar
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Argentina
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Angel Investors (October 2026)

The most active angel investors investing in Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
36 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Milad Alucozai
Angel
26 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $113k–$60M
Christopher Gibson
Angel
18 United States, United Kingdom, France Series A, Seed, Series B Biotechnology, Health Care, Pharmaceutical $1.5M–$55M
Jeffrey Dean
Angel
16 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Artificial Intelligence, Software, Information Technology $500k–$60M
Sahin Boydas
Angel
16 United States, Canada, Mexico Seed, Series A, Series B Artificial Intelligence, Software, Information Technology $500k–$150M
Charlie Songhurst
Angel
14 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$24M
Jude Gomila
Angel
13 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $70k–$4.7M
Paul Buchheit
Angel
12 United States, Canada, India Seed, Series A, Angel Software, Artificial Intelligence, SaaS $100k–$14M
Sam Altman
Angel
12 United States, Canada, Ghana Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.2M–$100M
Edward Lando
Angel
12 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, FinTech, Artificial Intelligence $125k–$31M
Balaji Srinivasan
Angel
11 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Software $650k–$28M
Jaffray Woodriff
Angel
10 United States Seed, Series A, Angel Software, Biotechnology, Health Care $250k–$11M
Farzad Nazem
Angel
10 United States, Canada Seed, Series A, Series B Health Care, Software, Analytics $750k–$50M
bumpkins profile
Angel
9 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Medical $500k–$57M
Alice Zhang
Angel
9 United States, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Therapeutics $120k–$30M
Kingsley Advani
Angel
9 United States, Singapore, United Kingdom Seed, Pre-Seed, Series A FinTech, Financial Services, Biotechnology $120k–$183M
Ling Wong
Angel
9 United States, Colombia Seed, Series A, Series C Health Care, Biotechnology, Medical $4.4M–$450M
Jeff Hammerbacher
Angel
9 United States, Germany Seed, Series A, Angel Artificial Intelligence, Software, Biotechnology $330k–$25M
Dimitri Seas
Angel
8 United States, Hong Kong, United Kingdom Seed, Pre-Seed, Series A Robotics, Health Care, Artificial Intelligence $231k–$4.2M
Jim Mellon
Angel
8 United States, United Kingdom, Israel Series A, Seed Biotechnology, Food and Beverage, Food Processing $894k–$47M
John Ballantyne
Angel
7 United States, Singapore Seed, Series A, Angel Health Care, Biotechnology, Therapeutics $4.5M–$30M
Esther Dyson
Angel
7 United States, Egypt, Canada Seed, Series A, Angel Health Care, Software, Artificial Intelligence $300k–$16M
Bradley Horowitz
Angel
7 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $150k–$36M
Elad Gil
Angel
7 United States, United Kingdom, Israel Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $2M–$117M
Nadav Rosenberg
Angel
7 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $1.1M–$21M
Chris Gibson
Angel
7 United States, France, Switzerland Series A, Seed Biotechnology, Health Care, Life Science $4.9M–$55M
Wei Guo
Angel
7 United States, China, Canada Seed, Series A, Angel Software, Artificial Intelligence, Internet $150k–$19M
Rand Hindi
Angel
7 France, United States, Germany Seed, Pre-Seed Cryptocurrency, Software, Machine Learning $125k–$11M
Erik Peterson
Angel
7 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, SaaS, Mobile $69k–$20M
Daniel Curran
Angel
6 United States, Canada, Brazil Seed, Series A, Series B Software, E-Commerce, Internet $230k–$50M
Kevin Moore
Angel
6 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $190k–$4M
Tim Draper
Angel
6 United States, United Kingdom, Canada Seed, Series A, Series B Software, FinTech, Financial Services $350k–$50M
Peter Thiel
Angel
6 United States, Germany, Canada Series A, Seed, Series B Software, FinTech, Financial Services $1.2M–$105M
Sake Bosch
Angel
6 The Netherlands, France, Israel Seed, Series A, Series B Software, E-Commerce, Biotechnology $1.3M–$77M
Nadav Ben-Chanoch
Angel
6 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Artificial Intelligence $120k–$30M
Eric Kwan
Angel
6 United States, India, Canada Seed, Pre-Seed, Series A Software, FinTech, E-Commerce $125k–$21M
Evan Cheng
Angel
6 United States, United Kingdom, Australia Seed, Pre-Seed, Series A Software, Artificial Intelligence, Biotechnology $120k–$18M
Zach Weinberg
Angel
6 United States, Israel, Colombia Seed, Series A, Pre-Seed Software, Health Care, SaaS $1.5M–$30M
Anne Wojcicki
Angel
6 United States, United Kingdom, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$70M
Cory Levy
Angel
6 United States, Canada, Peru Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $200k–$72M
Maxim Basov
Angel
6 Russian Federation, United States Seed, Angel, Pre-Seed Health Care, Apps, Legal $1.1M–$1.5M
Bill Gates
Angel
6 United States, Canada, Israel Series C, Series A, Series B Energy, Biotechnology, Renewable Energy $12M–$161M
Stefano Bernardi
Angel
6 Italy, United Kingdom, Canada Seed, Pre-Seed Blockchain, Software, Biotechnology $100k–$18M
Marc Benioff
Angel
6 United States, United Kingdom, Canada Series A, Seed, Series B Software, Health Care, Artificial Intelligence $850k–$50M
Vishal Rao
Angel
5 United States, India, Canada Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$25M
Benjamin Kong
Angel
5 United States, Israel, United Kingdom Seed, Pre-Seed Biotechnology, Blockchain, Cryptocurrency $750k–$8.7M
David R. Walt
Angel
5 United States Seed, Series A, Series B Biotechnology, Genetics, Life Science $2M–$37M
Daniel Schryer
Angel
5 United States, India, Panama Seed, Series B, Angel Software, Internet, Mobile $25k–$50M
Thomas Tull
Angel
5 United States Series A, Series C, Series B Artificial Intelligence, Software, Machine Learning $12M–$250M
Todd Corenson
Angel
5 United States Seed, Pre-Seed, Convertible Note Biotechnology, FinTech, SaaS $50k–$4.4M
Access all 3296 angel investors in Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 36 investments in Biotech startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 63
  • Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 26 investments in Biotech startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1M–$7M; Pre-Seed $113k–$5M; Series A $13M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Show all investments...

Christopher Gibson
Angel · Salt Lake City, Utah, United States · 18 investments in Biotech startups

Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 28
  • Round size: Seed $1.5M–$14M; Series A $10M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zanskar — Zanskar combines field geology, artificial intelligence, and computational geoscience to discover geothermal resources and develop clean, firm power.
  • Play Health — Play Health is no longer available. The team behind it is now building Paceline Bio.
  • Dunia Innovation — Catalysing the energy transition.
Show all investments...

Jeffrey Dean
Angel · Palo Alto, California, United States · 16 investments in Biotech startups, 21 in the past 12 months

Jeff Dean is the Co-founder and CEO of DiscoveryLoop. He previously worked at Google as Chief Scientist at Google DeepMind and Google Research. Jeff attended the University of Washington, where he earned a PhD in Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 111
  • Round size: Seed $2.5M–$34M; Pre-Seed $500k–$3M; Series A $10M–$60M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
  • Phinity Labs — Phinity Labs builds AI systems designed to fully automate the entire silicon microchip engineering process, spanning from original architectural concepts to final manufacturing preparation.
  • Volantis — Volantis specializes in developing AI-driven semiconductor solutions. The company focuses on creating advanced systems that support high-performance computing for various applications, including networking, data centers, and edge computing. Volantis provides integrated hardware and software platforms designed to optimize processing power, energyefficiency, and scalability. Their technology aims to enhance the capabilities of existing infrastructure, making it adaptable to emerging computational demands. The company's solutions cater to industries that require robust, efficient computing power at scale.
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 16 investments in Biotech startups

Sahin Boydas is the Founder & CEO of Lovie.co. He is part of PEF Community as PEF Chapter Lead.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 290
  • Round size: Seed $500k–$15M; Series A $8M–$36M; Series B $23M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lamb Labs — Lamb Labs is building model processing units that hardcode AI models into silicon for faster, more efficient inference.
  • Normal Computing — Normal Computing was founded by former members of the Google Brain Team, Palantir, and X who unlocked AI for some of the largest-scale and most mission-critical production systems, and the industry leading ML frameworks for Probabilistic and Quantum AI.
  • Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 14 investments in Biotech startups, 25 in the past 12 months

Charlie Songhurst is a private investor in technology companies. He previously worked at Microsoft as Head of Corporate Strategy. Charlie attended the University of Oxford.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 259
  • Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.1M; Series A $2.9M–$24M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Zeit AI — Zeit AI, founded by former Palantir engineers, generates a structured data base atop your tabular data files which you can query using natural language. For example, you suspect an efficiency in your organisation and you have a bunch of data files, instead of reading through all of them one by one in excel, you explore them in Zeit AI. Theycurrently offer a two-week pilot program where their engineers develop tailored solutions for data challenges involving CSV, Excel, or PDF files.
  • Mantic — Mantic is a world-class technical team on a mission to solve the next AI grand challenge: predicting global events with superhuman accuracy, and deploying this capability to power radically improved decision-making in business and government.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 13 investments in Biotech startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 67
  • Round size: Seed $1.4M–$4.7M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Clara — Primary care, supported by AI, that never closes, never rushes you, and never forgets the details.
  • Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 12 investments in Biotech startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 158
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — We build products that feel personal, magical and deeply human
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Sam Altman
Angel · San Francisco, California, United States · 12 investments in Biotech startups

Sam Altman is the Co-Founder and CEO of OpenAI. Sam previously served as Board Chair at Helion Energy.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Ghana

Investor stats

  • Total investments: 199
  • Round size: Seed $1.2M–$9.3M; Series A $10M–$50M; Series B $17M–$100M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
  • Preventive — Preventive mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children.
  • Red Queen Bio — Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine. But the same tools are also lowering the barrier for bad actors to engineer dangerous pathogens, and opening up an entirely new category of threats, including viruses designed to evade human immunity.Defense has to keep pace with offense.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 12 investments in Biotech startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 581
  • Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5M–$31M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Humera — Humera - AI CAPTCHA That Knows You're Human
  • Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
  • Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Balaji Srinivasan
Angel · San Francisco Bay Area, California, United States · 11 investments in Biotech startups, 14 in the past 12 months

Balaji Srinivasan is based out of Singapore, Central Region and is the Founder, Investor, and Author of Network School. Balaji previously worked at Coinbase as a CTO. Balaji Srinivasan attended Stanford University.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 276
  • Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
  • Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
  • Physical Superintelligence — Physical Superintelligence develops physical superintelligence systems that use AI-driven research to study physics, engineer physical systems, and explore new physical laws. Its approach combines human scientists with virtual physicists that conduct autonomous research campaigns covering hypothesis development, verification, experimentation,engineering, and deployment. The company focuses initially on the physical infrastructure underlying AI, including energy, materials, computation, sensing, and manufacturing.
Show all investments...

Jaffray Woodriff
Angel · Charlottesville, Virginia, United States · 10 investments in Biotech startups

Angel Investor located in Charlottesville, VA

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 47
  • Round size: Seed $640k–$4.3M; Angel $250k–$2.6M; Series A $3.4M–$11M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
  • Caju AI — Caju AI revolutionizes customer engagement with Generative AI, boosting your workforce's productivity and providing invaluable business insights. Elevate your customer experience with the power of AI.
  • Starchive — Starchive builds and runs the archives of the greatest bands and artists: IP, catalog, estate and ephemera. Then our creative lab brings them to life.
Show all investments...

Farzad Nazem
Angel · Palo Alto, California, United States · 10 investments in Biotech startups

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 130 early stage companies, and sits on the boards of Hand Foundation, and Nautilus Bio. His area of investment is about half in AI, Big Data and Cloud platforms, and half in Health and Biotech. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Show more...

Investment focus

  • Industry: Health Care, Software, Analytics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 65
  • Round size: Seed $750k–$6.5M; Series A $2.8M–$14M; Series B $6M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
  • Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
  • TigerGraph — TigerGraph is the leading graph database for real-time AI and analytics. Detect fraud, resolve entities, and uncover hidden connections at enterprise scale.
Show all investments...

bumpkins profile
Angel · 9 investments in Biotech startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.3M–$9.1M; Pre-Seed $500k–$2M; Series A $6.8M–$57M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Show all investments...

Alice Zhang
Angel · San Francisco, California, United States · 9 investments in Biotech startups

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $120k–$5.9M; Series A $12M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Show all investments...

Kingsley Advani
Angel · San Francisco, California, United States · 9 investments in Biotech startups

Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $120k–$8.3M; Pre-Seed $120k–$4.5M; Series A $4M–$183M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Checkstep — Moderate text, image, video and audio in 100+ languages with 98% accuracy. Cut moderation costs 90% and stay DSA and OSA compliant. Book a demo.
  • Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
  • Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
Show all investments...

Ling Wong
Angel · Seattle, Washington, United States · 9 investments in Biotech startups

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Series C
  • Geography: United States, Colombia

Investor stats

  • Total investments: 44
  • Round size: Seed $4.4M–$19M; Series A $8.1M–$36M; Series C $50M–$450M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
  • Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
Show all investments...

Jeff Hammerbacher
Angel · New York, New York, United States · 9 investments in Biotech startups

Jeff Hammerbacher is based out of New York and is the Chairman and Co-Founder of Ortet. Jeff previously worked at New Mountain Capital as a Senior Advisor and Portfolio Company Board Member. Jeff Hammerbacher attended Harvard University.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: United States, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$20M; Angel $330k–$330k; Series A $3M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Lamin — Improve your workflows with open-source data access and long-term memory. Query, trace, and govern with a lineage-native, format-agnostic lakehouse for agents and teams. With support for biological formats and registries.
  • Ridge AI — Ridge builds interactive dashboards and AI data agents you can embed in your product, so customers see the value you deliver. Start a free trial.
  • United Manufacturing Hub — The United Manufacturing Hub is an Open-Source Industrial IoT Infrastructure Platform enabling to easily connect, configure, manage, and maintain their factory.
Show all investments...

Dimitri Seas
Angel · Seattle, Washington, United States · 8 investments in Biotech startups

The founder of 2GIS

Show more...

Investment focus

  • Industry: Robotics, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Hong Kong, United Kingdom

Investor stats

  • Total investments: 13
  • Round size: Seed $231k–$4.2M; Pre-Seed $365k–$1.7M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Splatica — We turn a 3–5 minute 360° walk-through into a robotic simulation-ready digital twin — fully reconstructed, labeled, and exportable to Isaac Sim in under 24 hours. With 1,500+ scenes built, paying robotics customers, and early revenue, we’re building the infrastructure layer that supplies real-world environments for large-scale robot training.Splatica enables the last mile of sim-to-real — at scale.Finalist of Nebius / Nvidia Physical AI awards.
  • Welltory — Your personal data analyzed and transformed into powerful insights that keep you on track for lifelong health
  • Fluence Cloud — Decentralized and serverless computing, powering the cloudless internet
Show all investments...

Jim Mellon
Angel · 8 investments in Biotech startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 35
  • Round size: Seed $894k–$20M; Series A $3M–$47M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Callers AI — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share is a new Caribbean “quirky” golden rum from the islands of Barbados and Jamaica.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
John Ballantyne
Angel · Fargo, North Dakota, United States · 7 investments in Biotech startups

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Angel
  • Geography: United States, Singapore

Investor stats

  • Total investments: 11
  • Round size: Seed $4.5M–$7M; Series A $12M–$30M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • SmartWorx — AI-native platform for regulated, high-stakes environments. Purpose-built to solve the hardest integration and workflow problems where compliance isn't optional.
  • GlucoTrack — We are pleased to announce that the diabetes technology business focused on developing our Continuous Blood Glucose Monitor (CBGM) platform will now operate
Show all investments...

Esther Dyson
Angel · New York, New York, United States · 7 investments in Biotech startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Seed, Series A, Angel
  • Geography: United States, Egypt, Canada

Investor stats

  • Total investments: 93
  • Round size: Seed $300k–$4M; Angel $330k–$2.9M; Series A $1.5M–$16M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
  • Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 7 investments in Biotech startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 137
  • Round size: Seed $150k–$18M; Pre-Seed $500k–$6.6M; Series A $7.5M–$36M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 7 investments in Biotech startups, 19 in the past 12 months

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 263
  • Round size: Seed $2M–$17M; Series A $9.5M–$50M; Series B $27M–$117M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
  • Harvey — Harvey is an artificial intelligence technology service provider.
  • Cognition — Cognition develops artificial intelligence systems for software engineering and code automation. The company operates Devin, an AI software engineer that plans, writes, tests, debugs, and deploys code through integrated development workflows. Its platform works with existing development tools and codebases to support engineering tasks acrossapplication development, maintenance, and issue resolution. Cognition also provides tools that assist teams with system design, technical workflows, and collaborative coding processes. The company focuses on AI agents that automate repetitive engineering work while supporting software teams in managing complex development tasks.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 7 investments in Biotech startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 7 investments in Biotech startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
  • Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Show all investments...

Wei Guo
Angel · San Francisco, California, United States · 7 investments in Biotech startups

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr, Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 183
  • Round size: Seed $150k–$4.3M; Angel $375k–$10M; Series A $7M–$19M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
  • Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.
Show all investments...

Rand Hindi
Angel · Paris, Ile-de-France, France · 7 investments in Biotech startups

Rand Hindi is based out of United States and is the General Partner of Unit Ventures. Rand previously worked at Naval Group as an Advisor. Rand Hindi attended Singularity University. Rand Hindi has been awarded Rising Star.

Show more...

Investment focus

  • Industry: Cryptocurrency, Software, Machine Learning
  • Stage:Seed, Pre-Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 40
  • Round size: Seed $2.6M–$11M; Pre-Seed $125k–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
  • Optimum — Optimum constitutes a decentralized, high-performance memory infrastructure tailored for use across various blockchains.
  • Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 7 investments in Biotech startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, SaaS, Mobile
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 65
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Show all investments...

Daniel Curran
Angel · San Francisco, California, United States · 6 investments in Biotech startups

Daniel Curran is the Founder and CEO at CustEx.com. He is retired from Angel investing due to a lack of exits.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Brazil

Investor stats

  • Total investments: 188
  • Round size: Seed $230k–$5M; Series A $3.4M–$16M; Series B $2.3M–$50M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
  • RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
  • GC Plus — Find Your Next Home Service Expert With Ease
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Kevin Moore
Angel · Dallas, Texas, United States · 6 investments in Biotech startups

Kevin Moore has 15 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 105
  • Round size: Seed $190k–$4M; Pre-Seed $800k–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Trace — AI orchestration layer for modern teams
  • Augmend — Create documentation and an AI assistant from any video.
Show all investments...

Tim Draper
Angel · San Francisco, California, United States · 6 investments in Biotech startups, 19 in the past 12 months

Tim Draper is the Founding Partner of Draper Associates. He attended Harvard Business School.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 328
  • Round size: Seed $350k–$5.9M; Series A $2.5M–$25M; Series B $3M–$50M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • CASIMIR —
  • illumicell AI — illumicell AI combines patented AI algorithms and proprietary microscopy technology to test 50x faster, 20x more effectively, empowering every healthcare provider at the point of care – not just fertility clinics – with accessible, scalable fertility diagnostics.
  • SignalRank — SignalRank owns a growing asset portfolio of top performing venture backed companies. It enters at Series B by helping early stage investors maintain their ownership in their best assets. The resulting portfolio is a top decile venture performer since inception in May 2023. SignalRank finances early stage investors’ pro-rata in qualifying Series B rounds through an automated process designed for speed, high-conviction selection, and partner-aligned economics. it can decide inside 24 hours and fund in less than a week. As a result SignalRank has 300+ seed partners who invite it to partner for pro-rata financing in their fastest growing companies. It sees a high percentage of all Series B term sheets prior to close. Capital is supplied from SignalRank’s balance sheet, with no capital calls or partner IC process delays. Check size correlates with capital available. SignalRank handles SPV setup and ongoing administration, with a target of moving from partner allocation request to funding in 5 business days. 20% of the profit on each investment goes directly to partners. SignalRank creates deal-by-deal SPVs; SignalRank does not charge management fees for this partner product. The portfolio can be seen at - https://signalrank.com/signalrank-index.html
Show all investments...

Peter Thiel
Angel · San Francisco, California, United States · 6 investments in Biotech startups, 16 in the past 12 months

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 276
  • Round size: Seed $1.2M–$10M; Series A $3.9M–$32M; Series B $17M–$105M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Etched — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
  • Panthalassa — We're harnessing renewable energy in the open ocean and delivering it around the world. Engineered in Portland, Oregon.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 6 investments in Biotech startups

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$7.2M; Series A $6.9M–$29M; Series B $7.1M–$77M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Alfa AI — Alfa AI sources, screens and shortlists candidates so your team only spends time on the people worth meeting.
  • TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
  • Recupere Metals — Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 6 investments in Biotech startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Swaap — We build & operate onchain trading systems. We are a group of scientists and technologists committed to build open systems.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Skedway connects software, AI, sensors, displays and automation into one intelligent operational layer for the physical workplace.
Show all investments...

Eric Kwan
Angel · San Francisco, California, United States · 6 investments in Biotech startups

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Show more...

Investment focus

  • Industry: Software, FinTech, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 58
  • Round size: Seed $1M–$9M; Pre-Seed $125k–$2M; Series A $3.4M–$21M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Treinta — Treinta powers 7 million SMBs across the US and Latin America with simple finance, inventory, and sales tools.
  • Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
  • Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot
Show all investments...

Evan Cheng
Angel · Burlingame, California, United States · 6 investments in Biotech startups

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Australia

Investor stats

  • Total investments: 28
  • Round size: Seed $120k–$5.8M; Pre-Seed $150k–$10M; Series A $3M–$18M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jarsy — Start investing in Pre-IPO Companies with as little as $10. Jarsy is a pre-ipo marketplace platform that enables individuals worldwide to participate in top-tier private unicorns opportunities using stablecoins.
  • Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
  • Kite AI — An agnetic payment infrastructure empowering autonomous agents can operate with trust, governance, and native stablecoin settlement
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 6 investments in Biotech startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, Colombia

Investor stats

  • Total investments: 77
  • Round size: Seed $1.5M–$7.6M; Pre-Seed $1.5M–$2.3M; Series A $5M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Crosby — Crosby is an AI-first law firm that reviews contracts in under an hour. NDAs, MSAs, and DPAs handled with expert lawyers and AI working together.
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Show all investments...

Anne Wojcicki
Angel · San Francisco, California, United States · 6 investments in Biotech startups

Anne E. Wojcicki is based out of Palo Alto, California and is the Co Founder & Member of the board of 23andMe. Anne previously worked at Passport Capital as a Healthcare Analyst. Anne E. Wojcicki attended the Yale University. Anne E. Wojcicki has been received the Top CEO award.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 65
  • Round size: Seed $1M–$12M; Series A $7M–$70M; Series B $19M–$63M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Nix, Inc. — Wearable single-use hydration sensor for athletes, soldiers, and laborers that measures hydration levels and informs when, what, and how much to drink.
  • The Invention Network — ScaleIP is an IP business intelligence platform that helps companies monetize IP.
  • Clair Health — Clair Health is building the first noninvasive wearable continuous hormone monitor. Track estrogen, progesterone, LH, FSH, and PdG in real-time. Join the Clair Health waitlist.
Show all investments...

Cory Levy
Angel · San Francisco, California, United States · 6 investments in Biotech startups, 8 in the past 12 months

Cory Levy is the Founder of Z Fellows. He previously worked at DoSomething.org as a Board Member. Cory attended University of Illinois Urbana-Champaign, where he took Computer Science.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Canada, Peru

Investor stats

  • Total investments: 77
  • Round size: Seed $1.6M–$15M; Pre-Seed $200k–$3.3M; Series A $14M–$72M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Fun — Fun offers the highest converting rails to execute blockchain actions. Optimize your funding rails, reach new customers, and reduce costs.
  • Ghost — Ghost is a consumer hardware and software company building a private, local-first computing system for personal artificial intelligence.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Maxim Basov
Angel · Dubai, Dubai, United Arab Emirates · 6 investments in Biotech startups

Maxim Basov

Show more...

Investment focus

  • Industry: Health Care, Apps, Legal
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Russian Federation, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $1.1M–$1.5M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Welltory — Your personal data analyzed and transformed into powerful insights that keep you on track for lifelong health
  • Elementaree — Elementaree makes food personal every day and delivers it on a subscription basis to the doorstep. We create personal food programs catered to particular needs and goals whether it’s about losing weight, creating tasty meals for your family or increasing your body muscles. Unique personalized programs at cost of a standard grocery check. We adoptour expertise in building value chains which allows us to customize at scale. A never-repeating variety of everyday menus and personalized add-ons catered to customers' specific needs.
  • Synchronization — Synchronization is an online course for music, philosophy, fashion and design, architecture, art, psychology, special projects, master classes, and cinema. They provide biology and a healthy lifestyle, film history, and film language.
Show all investments...

Bill Gates
Angel · Washington, District of Columbia, United States · 6 investments in Biotech startups

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Renewable Energy
  • Stage:Series C, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 95
  • Round size: Series A $12M–$105M; Series B $14M–$161M; Series C $14M–$135M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Koloma — Koloma is revolutionizing clean energy by harnessing naturally occurring hydrogen from deep within the Earth.
  • TerraPower — Leading innovations in nuclear applications for reactor and storage technology, while advancing methods to transform the fight against cancer.
  • Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 6 investments in Biotech startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Blockchain, Software, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, Canada

Investor stats

  • Total investments: 18
  • Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Building the monetization layer for your alpha
  • Niulinx — Politecnico di Milano spin-off building autonomous driving technology.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Marc Benioff
Angel · San Francisco, California, United States · 6 investments in Biotech startups, 6 in the past 12 months

Marc Benioff is based out of San Francisco, California, and is the Chairman, Chief Executive Officer, and Co-Founder of Salesforce. Marc previously worked at Oracle Corporation as a Senior Vice President. Marc Benioff attended the University of Southern California.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 207
  • Round size: Seed $850k–$11M; Series A $5.9M–$30M; Series B $7M–$50M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
  • Panthalassa — We're harnessing renewable energy in the open ocean and delivering it around the world. Engineered in Portland, Oregon.
  • Factory — Factory is bringing autonomy to software engineering.
Show all investments...

Vishal Rao
Angel · Boston, Massachusetts, United States · 5 investments in Biotech startups

Advisory CTO and Angel Investor

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 84
  • Round size: Seed $500k–$8.8M; Pre-Seed $500k–$2.1M; Series A $3.8M–$25M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Aquaria — Aquaria provides solutions to secure access to clean water. The organization adapts its approaches based on the needs of these communities. It addresses water-related challenges through various methods.
  • Delphi — Delphi turns your expertise into an always-on presence, so you can grow your reach, serve your audience, and lead with clarity, without burning out.
  • Cambridge Terahertz — Cambridge Terahertz, a leader in terahertz (THz) imaging technology, offers an AI-powered Concealed Weapons Detection (CWD) solution to enhance workplace security. Our patent-pending system can see through clothing, luggage, plastic, paper, ceramics, and cardboard to detect concealed threats, including firearms, knives, and explosives.
Show all investments...

Benjamin Kong
Angel · San Francisco, California, United States · 5 investments in Biotech startups

Benjamin Kong is a Canadian investor backing early-stage transformative startups in Space, Biotech, Life Sciences, AI, Longevity, and Blockchain. He started investing in 2014 and has since funded over 50 startups and 3 VC funds. Recent early stage investments include Luminous Computing, Orbit Fab, Relativity Space, Swarm, TransAstra, RadianAerospace, Volumetric, OISIN, OncoSenX, Aegis BioDefense, Excision Biotherapeutics, MAIA Biotechnology, Ashvattha Therapeutics, ZenGo, Coinbase, Algorand, Oasis Labs, Arweave.

Show more...

Investment focus

  • Industry: Biotechnology, Blockchain, Cryptocurrency
  • Stage:Seed, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 18
  • Round size: Seed $750k–$8.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Radian — Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
  • Volumetric — Advanced materials and 3D biofabrication.
  • Excision BioTherapeutics — Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Show all investments...

David R. Walt
Angel · Boston, Massachusetts, United States · 5 investments in Biotech startups

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 8
  • Round size: Seed $2M–$5M; Series A $18M–$25M; Series B $5.4M–$37M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Vizgen — Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The highthroughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.
  • Stoicheia — NAGASPIN99 adalah link situs slot gacor hari ini yang menawarkan bonus berlimpah khusus pemain baru. Klik Daftar dan raih kemenangan besar bersama naga api sekarang juga.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Daniel Schryer
Angel · , Bali, Indonesia · 5 investments in Biotech startups

Dan Schryer was formerly CEO of DCI Data Centers, a Blackstone backed technology real estate company. Together with Guru Gowrappan, formerly CEO of Verizon Media, he co-founded Bali Venture Partners, LLC to invest in seed and growth stage debt and equity opportunities.

Show more...

Investment focus

  • Industry: Software, Internet, Mobile
  • Stage:Seed, Series B, Angel
  • Geography: United States, India, Panama

Investor stats

  • Total investments: 37
  • Round size: Seed $25k–$2M; Angel $75k–$670k; Series B $150k–$50M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • 54gene — 54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations.54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research iscaucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
  • Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
  • SOS Hydration — Rescue yourself from dehydration with SOS, doctor formulated rapid hydration with 80x less sugar than sports drinks and only 3g carbs and 10 calories.
Show all investments...

Thomas Tull
Angel · 5 investments in Biotech startups

Thomas Tull is the founder, chairman, and chief executive officer of Legendary Entertainment, a media company that produces content for mainstream audiences.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Series A, Series C, Series B
  • Geography: United States

Investor stats

  • Total investments: 45
  • Round size: Series A $12M–$60M; Series B $40M–$163M; Series C $40M–$250M
  • Lead/follow: 49% lead, 51% follow

Portfolio highlights

  • Slate Auto — Slate Auto | The Customizable EV That Works for You
  • Re:Build — Re:Build Manufacturing helps organizations move from concept to full-scale production by uniting design, engineering, and manufacturing to bring innovative products to market.
  • Colossal Biosciences — The science of genetics. The business of discovery.
Show all investments...

Todd Corenson
Angel · Los Gatos, California, United States · 5 investments in Biotech startups

Todd Corenson - Founder @ Enlon

Show more...

Investment focus

  • Industry: Biotechnology, FinTech, SaaS
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States

Investor stats

  • Total investments: 10
  • Round size: Seed $1M–$4.4M; Convertible Note $50k–$50k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
  • HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
  • iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.
Show all investments...

Biotech Angel investor funding at a glance

Stats across 2.7k deals from 3.3k investors.

3.3k
investors
in Biotech startups
2.7k
deals
in Biotech startups
$5.1M
median round
in Biotech startups
14%
lead investors
lead at least one round
32%
Seed
most common funding stage

Access all 3296 angel investors in Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 3296 angel investors investing in Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists